Earnings · China A-shares
Zhejiang Medicine Co., Ltd. Class A (600216) earnings
Zhejiang Medicine Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit -25.76% year on year, -28.46% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -9.99% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- -25.76%
- Excl. one-offs YoY
- -28.46%
- Net profit QoQ
- -72.80%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -7.71% | — |
| 3 days | -9.99% | — |
| 7 days | -4.49% | — |
| 14 days | -10.75% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 1 of 7 reports (average -2.63%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥692.80M | -25.76% | -28.46% | -6.71% | 0.72 | 6.14% | -9.99% | — | — |
| 2026 interim report | 2026-08-26 | ¥606.02M | -9.99% | -15.05% | +1.46% | 0.63 | 5.37% | +2.49% | -5.28% | +1.71% |
| 2026 Q1 report | 2026-04-24 | ¥287.01M | -29.84% | -31.89% | -2.86% | 0.30 | 2.59% | -0.27% | -18.91% | -19.33% |
| 2025 annual report | 2026-04-11 | ¥873.38M | -24.74% | -28.10% | -5.28% | 0.91 | 8.05% | -4.32% | -19.85% | -26.24% |
| 2025 Q3 report | 2025-10-28 | ¥933.15M | +9.83% | +5.30% | -5.87% | 0.97 | 8.49% | -0.14% | -3.26% | +0.12% |
| 2025 interim report | 2025-08-26 | ¥673.31M | +113.52% | +110.10% | -1.87% | 0.70 | 6.13% | -4.59% | -11.87% | -13.54% |
| 2025 Q1 report | 2025-04-24 | ¥409.09M | +273.08% | +279.23% | +0.28% | 0.43 | 3.77% | -1.62% | +9.92% | +7.65% |
| 2024 annual report | 2025-04-24 | ¥1.16B | +170.11% | +656.77% | +20.29% | 1.21 | 11.43% | -1.62% | +9.92% | +7.65% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.